What Telehealth Psychiatry Can and Can't Treat

Quick answer: Telehealth psychiatry is well-suited for most outpatient psychiatric care: evaluation, diagnosis, and medication management for depression, anxiety, ADHD, insomnia, PTSD, OCD, and many other conditions. It is less appropriate — or requires in-person follow-up — for active psychiatric crises (active suicidality, psychosis with safety concerns), conditions requiring physical examination, certain controlled-substance prescribing situations under state law, severe substance use detox, and patients who simply do not have a private, stable internet environment. For most adults, however, telehealth is clinically equivalent to in-person care, with similar treatment outcomes documented in published research.

Telehealth psychiatry has gone from a pandemic-era workaround to a mainstream way of receiving care. The clinical evidence is strong: for the majority of outpatient psychiatric conditions, virtual visits produce treatment outcomes equivalent to in-person care, with the added benefit of lower drop-out rates because the barrier to showing up is so much lower.

But "most" is not "all." A clear-eyed picture of what telehealth handles well and where it does not is important — both to set realistic expectations and to know when to ask for an in-person option.

What Telehealth Psychiatry Handles Well

For most adults presenting for outpatient psychiatric care, telehealth is a clinically appropriate first choice:

  • Depression — initial evaluation, medication selection, and longitudinal medication management all translate well to video. The clinical interview — which is the core of psychiatric assessment — does not require touch.
  • Anxiety disorders (generalized anxiety, panic, social anxiety) — virtual visits can actually reduce avoidance for patients whose anxiety makes in-person appointments themselves a barrier.
  • Adult ADHD — diagnosis (with appropriate symptom history and collateral information) and ongoing stimulant management are routinely handled via telehealth, subject to state controlled-substance rules covered below.
  • Insomnia — sleep history, hygiene counseling, and medication management all work well virtually.
  • PTSD — evaluation and medication management are appropriate; trauma-focused therapy specifically may benefit from either in-person or virtual format depending on the patient.
  • OCD — diagnosis and medication management work well; exposure work with a therapist can be effective in both formats.
  • Postpartum depression and anxiety — telehealth is often the only practical option for new parents, and outcomes are documented to be equivalent.
  • Medication management for stable patients — once a treatment regimen is working, periodic follow-ups by video are convenient and clinically equivalent.

For these conditions, the published evidence shows that telehealth psychiatry achieves similar symptom reduction, similar treatment adherence, and often higher patient satisfaction than equivalent in-person care.

What Is Borderline or Requires Extra Care

Some situations are not contraindications to telehealth, but they require thoughtful adjustments:

  • First-visit evaluations for new patients — clinically fine via video, but the technical setup matters more. A quiet, private room with stable internet on the patient's end is essential, and the psychiatrist will be more proactive about screening for safety, substance use, and physical symptoms that an in-person setting might surface incidentally.
  • Severe depression — appropriate if there is no active suicidal planning, but the threshold for moving to a higher level of care (in-person follow-up, IOP, hospitalization) is lower in a virtual context because the physician cannot intervene as immediately.
  • Bipolar disorder — manageable via telehealth in the maintenance phase; active manic or mixed episodes may need in-person evaluation.
  • Eating disorders — appropriate if a primary care physician or specialist is monitoring weight, vitals, and labs in parallel. Telehealth psychiatry alone does not capture the physical-status data that drives eating-disorder treatment decisions.
  • Adolescents — possible, but typically with a parent or guardian present for at least part of the visit, and with attention to where in the home the visit takes place.

When In-Person Care Is the Right Call

There are genuinely situations where in-person care is preferable or required:

  • Active psychiatric crisis — current suicidal intent with a plan, active psychotic symptoms with safety concerns, severe agitation. These need either an emergency room or, when appropriate, urgent in-person evaluation.
  • Conditions requiring physical examination — when a medical workup is needed (suspected hyperthyroidism, neurologic symptoms, certain medication side effects requiring vital signs).
  • Severe substance use disorders requiring medical detox — alcohol or benzodiazepine withdrawal can be life-threatening and requires an in-person medical setting.
  • Patients who lack a private, stable environment for visits — psychiatric care requires privacy. A patient who can only join visits from a noisy shared space, or whose home situation makes honest conversation impossible, is not well-served by telehealth regardless of clinical condition.
  • Patients who simply prefer in-person care — this is a legitimate preference, not a clinical deficit. Some people experience better therapeutic connection face-to-face.

Controlled Substances and State Law

This area changes frequently and matters specifically for stimulant prescribing (ADHD medication) and benzodiazepine prescribing:

  • The federal DEA has issued multiple extensions of pandemic-era telehealth flexibilities for controlled substance prescribing. The current rules permit telehealth prescribing of controlled substances in most situations, but the framework is still evolving.
  • State law matters — some states require an in-person visit before prescribing a controlled substance, or require in-person follow-up at specified intervals. Texas, for example, generally allows initiation and continuation of controlled-substance prescribing via telehealth for established treatment relationships, subject to evolving federal and state rules.
  • A practical implication: a psychiatrist who can only see you via telehealth and cannot offer an in-person option may not be able to prescribe certain medications even if they are clinically appropriate. Asking up front avoids a frustrating mid-treatment surprise.

At SLS Psychiatry, this is a topic we discuss directly during the initial evaluation — both the clinical question of whether a controlled substance is appropriate, and the practical question of what the current rules allow.

What the Technology Actually Needs

For telehealth psychiatry to work well, the patient side needs:

  • A device with a camera and microphone (laptop, tablet, or modern smartphone)
  • Stable internet — video freezing during a clinical interview is more disruptive than people expect
  • A private, quiet space where you are not going to be interrupted or overheard
  • A backup plan if technology fails (typically a phone number to call to switch to audio-only)

Patients sometimes underestimate the privacy requirement. A telehealth visit in your car parked in a driveway is very different from a telehealth visit standing in the kitchen with family members around. The clinical conversation requires the same privacy as an in-person visit.

When to Choose One or the Other

A reasonable framework:

  • Default to telehealth if you have a quiet space, stable internet, no active safety crisis, and your condition is one of the well-suited list above. The convenience translates directly to better treatment adherence over time.
  • Choose in-person if you have an active psychiatric crisis, need a physical examination, lack a private home environment, simply prefer face-to-face care, or are in a state with controlled-substance prescribing rules that require it.
  • Use a hybrid model if available — initial in-person evaluation followed by virtual follow-ups, or annual in-person check-ins with virtual visits in between. This is increasingly common and often the best of both formats.

Telehealth psychiatry at SLS is available statewide in Texas, with in-person options at the Southlake office for patients in the DFW area who prefer or need them.

Frequently asked questions

Can I get an ADHD diagnosis through telehealth?

Yes. A proper ADHD evaluation — detailed symptom history, screening for conditions that mimic ADHD, and a structured diagnostic interview — can be conducted thoroughly by video. The key is the quality and thoroughness of the evaluation, not the format of the visit.

Can I get prescribed stimulants through telehealth?

Generally yes, subject to evolving federal DEA rules and state-specific requirements. In Texas, established treatment relationships can usually include controlled-substance prescribing via telehealth. The specific rules change, so it is reasonable to ask your psychiatrist about current limitations at the start of treatment.

Is telehealth psychiatry covered by insurance?

In most states, including Texas, insurance coverage for telehealth psychiatry is required to be at parity with in-person care. Specifics vary by plan — checking with your insurer or with the practice up front avoids surprises.

What happens if I have a mental health emergency during a telehealth visit?

Your psychiatrist will have safety protocols, including knowing your physical location at the time of each visit and having emergency contact information. For an active crisis, the appropriate response is calling 988 or going to the nearest emergency room — and your psychiatrist can help coordinate that during or after a visit.

Is telehealth as effective as seeing someone in person?

For most outpatient psychiatric conditions, yes — multiple meta-analyses show equivalent symptom reduction, medication adherence, and patient satisfaction. The difference is logistical, not clinical, for the conditions where it is well-suited.

Sources

  1. APA — Telepsychiatry
  2. DEA — Telemedicine Regulations
  3. Texas Medical Board — Telemedicine